Iatrogenic immunosuppression with biologics in MS: expecting the unexpected? [electronic resource]
Producer: 20091202Description: 1346-7 p. digitalISSN:- 1526-632X
- Animals
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Clinical Trials as Topic
- Humans
- Iatrogenic Disease
- Immune Tolerance
- Integrin alpha4 -- metabolism
- Leukoencephalopathy, Progressive Multifocal -- chemically induced
- Male
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Natalizumab
- Risk
- Toxoplasma
- Toxoplasmosis, Ocular -- etiology
No physical items for this record
Publication Type: Comment; Editorial
There are no comments on this title.
Log in to your account to post a comment.